Cancer Vaccine Development
Inefficient cross-presentation limits response to tumor antigen epitope
Published in Vaccine Weekly, September 28th, 2005
"CD8+ T lymphocytes (TCD8 ) responding to subdominant epitopes provide alternate targets for the immunotherapy of cancer, particularly when self-tolerance limits the response to immunodominant epitopes. However, the mechanisms that promote TCD8 subdominance to tumor antigens remain obscure. We investigated the basis for the lack of priming against a subdominant tumor epitope following immunization of C57BL/6 (B6) mice with SV40 large tumor antigen (T Ag)-transformed cells," scientists in the United States report.
"Immunization...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2005-09-28)
More Articles from Vaccine Weekly
- Cancer Vaccine Development
DNA shows promise for cancer immunotherapy - Hookworm Vaccine Development
Antibodies against hookworm larvae protein reduce hookworm infection - Metapneumovirus Vaccine Development
Cotton rat is permissive small animal model of human metapneumovirus - Staphylococcus Vaccine Development
Vaccine protects against Staphylococcus aureus infection - Vector Development
Modified adenovirus vector allows stable gene expression - Adverse Drug Reaction
Report: Chicken pox vaccine associated with shingles epidemic - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
